Arthur Tzianabos Stoke Therapeutics, Inc. (STOK) insider trading activity

Arthur Tzianabos is of Stoke Therapeutics, Inc.. Currently has a direct ownership of 31,739 shares of STOK, which is worth approximately $333,576. The most recent transaction as insider was on Feb 13, 2024, when has been sold 31,739 shares (Common Stock) at a price of $2.19 per share, resulting in proceeds of $69,508. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31.7K

0% 3M change

Infinity% 12M change

Total Value Held $333,576

ARTHUR TZIANABOS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 13 2024	BUY Exercise of conversion of derivative security	$69,508 $2.19 p/Share	31,739 Added 50.0%	31,739 Common Stock
Feb 19 2021	SELL Open market or private sale	$606,700 $60.67 p/Share	10,000 Reduced 100.0%	0 Common Stock
Feb 19 2021	BUY Exercise of conversion of derivative security	$21,900 $2.19 p/Share	10,000 Added 50.0%	10,000 Common Stock
Nov 23 2020	SELL Open market or private sale	$927,600 $46.38 p/Share	20,000 Reduced 100.0%	0 Common Stock
Nov 23 2020	BUY Exercise of conversion of derivative security	$43,800 $2.19 p/Share	20,000 Added 50.0%	20,000 Common Stock

Also insider at

AKUS

Akouos, Inc. Healthcare

Director

FIXX

Homology Medicines, Inc. Healthcare